
VistaGen Therapeutics VTGN
€ 0.15
-5.19%
Land |
|
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
38.1 M |
Marktkapitalisierung |
$ 6.47 M |
EBITDA (LTM) |
$ -71.9 M |
P/E (LTM) |
-0.125654 |
P/S (LTM) |
8.24706 |
EPS (LTM) |
-1.91 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Cerevel Therapeutics Holdings
CERE
|
- | - | $ 7.29 B | Nasdaq Capital Market | ||
|
NexImmune
NEXI
|
- | 70.13 % | $ 4.12 M | Nasdaq Global Market | ||
|
Wave Life Sciences Ltd.
WVE
|
$ 3.23 | -0.16 % | $ 545 M | Nasdaq Global Select Market | ||
|
Theravance Biopharma
TBPH
|
$ 17.03 | 0.03 % | $ 857 M | Nasdaq Global Select Market | ||
|
Xenetic Biosciences
XBIO
|
$ 1.72 | 3.78 % | $ 2.93 M | Nasdaq Capital Market | ||
|
XBiotech
XBIT
|
$ 1.82 | -5.7 % | $ 55.5 M | Nasdaq Global Select Market | ||
|
Xenon Pharmaceuticals
XENE
|
$ 35.76 | 1.19 % | $ 2.83 B | Nasdaq Global Select Market | ||
|
Xeris Pharmaceuticals
XERS
|
$ 10.21 | 0.05 % | $ 1.64 B | Nasdaq Global Select Market | ||
|
X4 Pharmaceuticals
XFOR
|
$ 3.26 | 0.46 % | $ 138 M | Nasdaq Capital Market | ||
|
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market | ||
|
22nd Century Group
XXII
|
$ 0.09 | -54.43 % | $ 16.6 K | NYSE American | ||
|
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | ||
|
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | ||
|
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | ||
|
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | ||
|
Zai Lab Limited
ZLAB
|
$ 24.36 | 1.35 % | $ 26.7 B | Nasdaq Global Select Market | ||
|
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | ||
|
Zentalis Pharmaceuticals
ZNTL
|
$ 2.06 | -6.79 % | $ 148 M | Nasdaq Global Market | ||
|
Zymeworks
ZYME
|
$ 28.38 | 0.57 % | $ 1.46 B | NYSE | ||
|
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | ||
|
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | ||
|
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | ||
|
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | ||
|
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | ||
|
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | ||
|
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | ||
|
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | ||
|
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | ||
|
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | ||
|
Baudax Bio
BXRX
|
- | 0.59 % | $ 63 K | Nasdaq Capital Market | ||
|
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | ||
|
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | ||
|
Zosano Pharma Corporation
ZSAN
|
- | 7.23 % | $ 2.72 M | Nasdaq Global Select Market | ||
|
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | ||
|
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market | ||
|
Spectrum Pharmaceuticals
SPPI
|
- | - | $ 189 M | Nasdaq Global Select Market | ||
|
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | ||
|
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | ||
|
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | ||
|
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | ||
|
Vascular Biogenics Ltd.
VBLT
|
- | -8.77 % | $ 12.4 M | Nasdaq Global Select Market | ||
|
C4 Therapeutics
CCCC
|
$ 2.98 | -2.78 % | $ 247 M | Nasdaq Global Select Market | ||
|
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | ||
|
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | ||
|
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | ||
|
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | ||
|
Kaleido Biosciences
KLDO
|
- | -3.69 % | $ 12.4 M | Nasdaq Global Select Market | ||
|
VBI Vaccines
VBIV
|
- | -50.87 % | $ 1.09 M | Nasdaq Capital Market | ||
|
Certara
CERT
|
$ 10.61 | 2.66 % | $ 1.7 B | Nasdaq Global Select Market | ||
|
CTI BioPharma Corp.
CTIC
|
- | - | $ 1.2 B | Nasdaq Capital Market |